▶ 調査レポート

世界の間質血管分画市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Stromal Vascular Fraction Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の間質血管分画市場規模・現状・予測(2021年-2027年) / Global Stromal Vascular Fraction Market Size, Status and Forecast 2021-2027 / QYR2104Z5465資料のイメージです。• レポートコード:QYR2104Z5465
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥565,500 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥848,250 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,131,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、間質血管分画のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(SVF分離製品、酵素分離、非酵素分離、自動POCデバイス、SVF吸引精製製品、SVFトランスファー製品)、用途別市場規模(病院、専門クリニック、幹細胞バンク/研究所、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・間質血管分画の市場動向
・企業の競争状況、市場シェア
・間質血管分画の種類別市場規模(SVF分離製品、酵素分離、非酵素分離、自動POCデバイス、SVF吸引精製製品、SVFトランスファー製品)
・間質血管分画の用途別市場規模(病院、専門クリニック、幹細胞バンク/研究所、その他)
・間質血管分画の北米市場規模2016-2027(アメリカ、カナダ)
・間質血管分画のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・間質血管分画のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・間質血管分画の中南米市場規模2016-2027(メキシコ、ブラジル)
・間質血管分画の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Cytori Therapeutics、GE Healthcare、Ingeneron、Medikan International、Tissue Genesis、Genesis Biosystems、Human Med、IntelliCell BioSciences、LifeCell)
・結論

Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient’s own body.
With increasing age, regenerative and repair properties of skin are less effective due to decrease in stem cell count, and therefore, stromal vascular fraction treatment contains stem cell provides a boost in repair and maintenance mechanism of the skin leaving smooth, healthy, radiant skin.

Market Analysis and Insights: Global Stromal Vascular Fraction Market
The global Stromal Vascular Fraction market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stromal Vascular Fraction market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stromal Vascular Fraction market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stromal Vascular Fraction market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stromal Vascular Fraction market.

Global Stromal Vascular Fraction Scope and Market Size
Stromal Vascular Fraction market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Stromal Vascular Fraction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
SVF Isolation Products
Enzymatic Isolation
Non-enzymatic Isolation
Automated POC Devices
SVF Aspirate Purification Products
SVF Transfer Products

Segment by Application
Hospitals
Specialty Clinics
Stem Cell Banks/Laboratories
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Cytori Therapeutics
GE Healthcare
Ingeneron
Medikan International
Tissue Genesis
Genesis Biosystems
Human Med
IntelliCell BioSciences
LifeCell

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stromal Vascular Fraction Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 SVF Isolation Products
1.2.3 Enzymatic Isolation
1.2.4 Non-enzymatic Isolation
1.2.5 Automated POC Devices
1.2.6 SVF Aspirate Purification Products
1.2.7 SVF Transfer Products
1.3 Market by Application
1.3.1 Global Stromal Vascular Fraction Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Stem Cell Banks/Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Stromal Vascular Fraction Market Perspective (2016-2027)
2.2 Stromal Vascular Fraction Growth Trends by Regions
2.2.1 Stromal Vascular Fraction Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Stromal Vascular Fraction Historic Market Share by Regions (2016-2021)
2.2.3 Stromal Vascular Fraction Forecasted Market Size by Regions (2022-2027)
2.3 Stromal Vascular Fraction Industry Dynamic
2.3.1 Stromal Vascular Fraction Market Trends
2.3.2 Stromal Vascular Fraction Market Drivers
2.3.3 Stromal Vascular Fraction Market Challenges
2.3.4 Stromal Vascular Fraction Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Stromal Vascular Fraction Players by Revenue
3.1.1 Global Top Stromal Vascular Fraction Players by Revenue (2016-2021)
3.1.2 Global Stromal Vascular Fraction Revenue Market Share by Players (2016-2021)
3.2 Global Stromal Vascular Fraction Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Stromal Vascular Fraction Revenue
3.4 Global Stromal Vascular Fraction Market Concentration Ratio
3.4.1 Global Stromal Vascular Fraction Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stromal Vascular Fraction Revenue in 2020
3.5 Stromal Vascular Fraction Key Players Head office and Area Served
3.6 Key Players Stromal Vascular Fraction Product Solution and Service
3.7 Date of Enter into Stromal Vascular Fraction Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Stromal Vascular Fraction Breakdown Data by Type
4.1 Global Stromal Vascular Fraction Historic Market Size by Type (2016-2021)
4.2 Global Stromal Vascular Fraction Forecasted Market Size by Type (2022-2027)

5 Stromal Vascular Fraction Breakdown Data by Application
5.1 Global Stromal Vascular Fraction Historic Market Size by Application (2016-2021)
5.2 Global Stromal Vascular Fraction Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Stromal Vascular Fraction Market Size (2016-2027)
6.2 North America Stromal Vascular Fraction Market Size by Type
6.2.1 North America Stromal Vascular Fraction Market Size by Type (2016-2021)
6.2.2 North America Stromal Vascular Fraction Market Size by Type (2022-2027)
6.2.3 North America Stromal Vascular Fraction Market Size by Type (2016-2027)
6.3 North America Stromal Vascular Fraction Market Size by Application
6.3.1 North America Stromal Vascular Fraction Market Size by Application (2016-2021)
6.3.2 North America Stromal Vascular Fraction Market Size by Application (2022-2027)
6.3.3 North America Stromal Vascular Fraction Market Size by Application (2016-2027)
6.4 North America Stromal Vascular Fraction Market Size by Country
6.4.1 North America Stromal Vascular Fraction Market Size by Country (2016-2021)
6.4.2 North America Stromal Vascular Fraction Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Stromal Vascular Fraction Market Size (2016-2027)
7.2 Europe Stromal Vascular Fraction Market Size by Type
7.2.1 Europe Stromal Vascular Fraction Market Size by Type (2016-2021)
7.2.2 Europe Stromal Vascular Fraction Market Size by Type (2022-2027)
7.2.3 Europe Stromal Vascular Fraction Market Size by Type (2016-2027)
7.3 Europe Stromal Vascular Fraction Market Size by Application
7.3.1 Europe Stromal Vascular Fraction Market Size by Application (2016-2021)
7.3.2 Europe Stromal Vascular Fraction Market Size by Application (2022-2027)
7.3.3 Europe Stromal Vascular Fraction Market Size by Application (2016-2027)
7.4 Europe Stromal Vascular Fraction Market Size by Country
7.4.1 Europe Stromal Vascular Fraction Market Size by Country (2016-2021)
7.4.2 Europe Stromal Vascular Fraction Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Stromal Vascular Fraction Market Size (2016-2027)
8.2 Asia-Pacific Stromal Vascular Fraction Market Size by Type
8.2.1 Asia-Pacific Stromal Vascular Fraction Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Stromal Vascular Fraction Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Stromal Vascular Fraction Market Size by Type (2016-2027)
8.3 Asia-Pacific Stromal Vascular Fraction Market Size by Application
8.3.1 Asia-Pacific Stromal Vascular Fraction Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Stromal Vascular Fraction Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Stromal Vascular Fraction Market Size by Application (2016-2027)
8.4 Asia-Pacific Stromal Vascular Fraction Market Size by Region
8.4.1 Asia-Pacific Stromal Vascular Fraction Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Stromal Vascular Fraction Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Stromal Vascular Fraction Market Size (2016-2027)
9.2 Latin America Stromal Vascular Fraction Market Size by Type
9.2.1 Latin America Stromal Vascular Fraction Market Size by Type (2016-2021)
9.2.2 Latin America Stromal Vascular Fraction Market Size by Type (2022-2027)
9.2.3 Latin America Stromal Vascular Fraction Market Size by Type (2016-2027)
9.3 Latin America Stromal Vascular Fraction Market Size by Application
9.3.1 Latin America Stromal Vascular Fraction Market Size by Application (2016-2021)
9.3.2 Latin America Stromal Vascular Fraction Market Size by Application (2022-2027)
9.3.3 Latin America Stromal Vascular Fraction Market Size by Application (2016-2027)
9.4 Latin America Stromal Vascular Fraction Market Size by Country
9.4.1 Latin America Stromal Vascular Fraction Market Size by Country (2016-2021)
9.4.2 Latin America Stromal Vascular Fraction Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Stromal Vascular Fraction Market Size (2016-2027)
10.2 Middle East & Africa Stromal Vascular Fraction Market Size by Type
10.2.1 Middle East & Africa Stromal Vascular Fraction Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Stromal Vascular Fraction Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Stromal Vascular Fraction Market Size by Type (2016-2027)
10.3 Middle East & Africa Stromal Vascular Fraction Market Size by Application
10.3.1 Middle East & Africa Stromal Vascular Fraction Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Stromal Vascular Fraction Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Stromal Vascular Fraction Market Size by Application (2016-2027)
10.4 Middle East & Africa Stromal Vascular Fraction Market Size by Country
10.4.1 Middle East & Africa Stromal Vascular Fraction Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Stromal Vascular Fraction Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Cytori Therapeutics
11.1.1 Cytori Therapeutics Company Details
11.1.2 Cytori Therapeutics Business Overview
11.1.3 Cytori Therapeutics Stromal Vascular Fraction Introduction
11.1.4 Cytori Therapeutics Revenue in Stromal Vascular Fraction Business (2016-2021)
11.1.5 Cytori Therapeutics Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Stromal Vascular Fraction Introduction
11.2.4 GE Healthcare Revenue in Stromal Vascular Fraction Business (2016-2021)
11.2.5 GE Healthcare Recent Development
11.3 Ingeneron
11.3.1 Ingeneron Company Details
11.3.2 Ingeneron Business Overview
11.3.3 Ingeneron Stromal Vascular Fraction Introduction
11.3.4 Ingeneron Revenue in Stromal Vascular Fraction Business (2016-2021)
11.3.5 Ingeneron Recent Development
11.4 Medikan International
11.4.1 Medikan International Company Details
11.4.2 Medikan International Business Overview
11.4.3 Medikan International Stromal Vascular Fraction Introduction
11.4.4 Medikan International Revenue in Stromal Vascular Fraction Business (2016-2021)
11.4.5 Medikan International Recent Development
11.5 Tissue Genesis
11.5.1 Tissue Genesis Company Details
11.5.2 Tissue Genesis Business Overview
11.5.3 Tissue Genesis Stromal Vascular Fraction Introduction
11.5.4 Tissue Genesis Revenue in Stromal Vascular Fraction Business (2016-2021)
11.5.5 Tissue Genesis Recent Development
11.6 Genesis Biosystems
11.6.1 Genesis Biosystems Company Details
11.6.2 Genesis Biosystems Business Overview
11.6.3 Genesis Biosystems Stromal Vascular Fraction Introduction
11.6.4 Genesis Biosystems Revenue in Stromal Vascular Fraction Business (2016-2021)
11.6.5 Genesis Biosystems Recent Development
11.7 Human Med
11.7.1 Human Med Company Details
11.7.2 Human Med Business Overview
11.7.3 Human Med Stromal Vascular Fraction Introduction
11.7.4 Human Med Revenue in Stromal Vascular Fraction Business (2016-2021)
11.7.5 Human Med Recent Development
11.8 IntelliCell BioSciences
11.8.1 IntelliCell BioSciences Company Details
11.8.2 IntelliCell BioSciences Business Overview
11.8.3 IntelliCell BioSciences Stromal Vascular Fraction Introduction
11.8.4 IntelliCell BioSciences Revenue in Stromal Vascular Fraction Business (2016-2021)
11.8.5 IntelliCell BioSciences Recent Development
11.9 LifeCell
11.9.1 LifeCell Company Details
11.9.2 LifeCell Business Overview
11.9.3 LifeCell Stromal Vascular Fraction Introduction
11.9.4 LifeCell Revenue in Stromal Vascular Fraction Business (2016-2021)
11.9.5 LifeCell Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Stromal Vascular Fraction Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of SVF Isolation Products
Table 3. Key Players of Enzymatic Isolation
Table 4. Key Players of Non-enzymatic Isolation
Table 5. Key Players of Automated POC Devices
Table 6. Key Players of SVF Aspirate Purification Products
Table 7. Key Players of SVF Transfer Products
Table 8. Global Stromal Vascular Fraction Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Stromal Vascular Fraction Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Stromal Vascular Fraction Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Stromal Vascular Fraction Market Share by Regions (2016-2021)
Table 12. Global Stromal Vascular Fraction Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Stromal Vascular Fraction Market Share by Regions (2022-2027)
Table 14. Stromal Vascular Fraction Market Trends
Table 15. Stromal Vascular Fraction Market Drivers
Table 16. Stromal Vascular Fraction Market Challenges
Table 17. Stromal Vascular Fraction Market Restraints
Table 18. Global Stromal Vascular Fraction Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Stromal Vascular Fraction Market Share by Players (2016-2021)
Table 20. Global Top Stromal Vascular Fraction Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stromal Vascular Fraction as of 2020)
Table 21. Ranking of Global Top Stromal Vascular Fraction Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Stromal Vascular Fraction Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Stromal Vascular Fraction Product Solution and Service
Table 25. Date of Enter into Stromal Vascular Fraction Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Stromal Vascular Fraction Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Stromal Vascular Fraction Revenue Market Share by Type (2016-2021)
Table 29. Global Stromal Vascular Fraction Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Stromal Vascular Fraction Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Stromal Vascular Fraction Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Stromal Vascular Fraction Revenue Market Share by Application (2016-2021)
Table 33. Global Stromal Vascular Fraction Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Stromal Vascular Fraction Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Stromal Vascular Fraction Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Stromal Vascular Fraction Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Stromal Vascular Fraction Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Stromal Vascular Fraction Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Stromal Vascular Fraction Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Stromal Vascular Fraction Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Stromal Vascular Fraction Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Stromal Vascular Fraction Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Stromal Vascular Fraction Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Stromal Vascular Fraction Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Stromal Vascular Fraction Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Stromal Vascular Fraction Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Stromal Vascular Fraction Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Stromal Vascular Fraction Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Stromal Vascular Fraction Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Stromal Vascular Fraction Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Stromal Vascular Fraction Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Stromal Vascular Fraction Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Stromal Vascular Fraction Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Stromal Vascular Fraction Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Stromal Vascular Fraction Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Stromal Vascular Fraction Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Stromal Vascular Fraction Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Stromal Vascular Fraction Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Stromal Vascular Fraction Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Stromal Vascular Fraction Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Stromal Vascular Fraction Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Stromal Vascular Fraction Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Stromal Vascular Fraction Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Stromal Vascular Fraction Market Size by Country (2022-2027) & (US$ Million)
Table 65. Cytori Therapeutics Company Details
Table 66. Cytori Therapeutics Business Overview
Table 67. Cytori Therapeutics Stromal Vascular Fraction Product
Table 68. Cytori Therapeutics Revenue in Stromal Vascular Fraction Business (2016-2021) & (US$ Million)
Table 69. Cytori Therapeutics Recent Development
Table 70. GE Healthcare Company Details
Table 71. GE Healthcare Business Overview
Table 72. GE Healthcare Stromal Vascular Fraction Product
Table 73. GE Healthcare Revenue in Stromal Vascular Fraction Business (2016-2021) & (US$ Million)
Table 74. GE Healthcare Recent Development
Table 75. Ingeneron Company Details
Table 76. Ingeneron Business Overview
Table 77. Ingeneron Stromal Vascular Fraction Product
Table 78. Ingeneron Revenue in Stromal Vascular Fraction Business (2016-2021) & (US$ Million)
Table 79. Ingeneron Recent Development
Table 80. Medikan International Company Details
Table 81. Medikan International Business Overview
Table 82. Medikan International Stromal Vascular Fraction Product
Table 83. Medikan International Revenue in Stromal Vascular Fraction Business (2016-2021) & (US$ Million)
Table 84. Medikan International Recent Development
Table 85. Tissue Genesis Company Details
Table 86. Tissue Genesis Business Overview
Table 87. Tissue Genesis Stromal Vascular Fraction Product
Table 88. Tissue Genesis Revenue in Stromal Vascular Fraction Business (2016-2021) & (US$ Million)
Table 89. Tissue Genesis Recent Development
Table 90. Genesis Biosystems Company Details
Table 91. Genesis Biosystems Business Overview
Table 92. Genesis Biosystems Stromal Vascular Fraction Product
Table 93. Genesis Biosystems Revenue in Stromal Vascular Fraction Business (2016-2021) & (US$ Million)
Table 94. Genesis Biosystems Recent Development
Table 95. Human Med Company Details
Table 96. Human Med Business Overview
Table 97. Human Med Stromal Vascular Fraction Product
Table 98. Human Med Revenue in Stromal Vascular Fraction Business (2016-2021) & (US$ Million)
Table 99. Human Med Recent Development
Table 100. IntelliCell BioSciences Company Details
Table 101. IntelliCell BioSciences Business Overview
Table 102. IntelliCell BioSciences Revenue in Stromal Vascular Fraction Business (2016-2021) & (US$ Million)
Table 103. IntelliCell BioSciences Recent Development
Table 104. LifeCell Company Details
Table 105. LifeCell Business Overview
Table 106. LifeCell Stromal Vascular Fraction Product
Table 107. LifeCell Revenue in Stromal Vascular Fraction Business (2016-2021) & (US$ Million)
Table 108. LifeCell Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stromal Vascular Fraction Market Share by Type: 2020 VS 2027
Figure 2. SVF Isolation Products Features
Figure 3. Enzymatic Isolation Features
Figure 4. Non-enzymatic Isolation Features
Figure 5. Automated POC Devices Features
Figure 6. SVF Aspirate Purification Products Features
Figure 7. SVF Transfer Products Features
Figure 8. Global Stromal Vascular Fraction Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Stem Cell Banks/Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Stromal Vascular Fraction Report Years Considered
Figure 14. Global Stromal Vascular Fraction Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Stromal Vascular Fraction Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Stromal Vascular Fraction Market Share by Regions: 2020 VS 2027
Figure 17. Global Stromal Vascular Fraction Market Share by Regions (2022-2027)
Figure 18. Global Stromal Vascular Fraction Market Share by Players in 2020
Figure 19. Global Top Stromal Vascular Fraction Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stromal Vascular Fraction as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Stromal Vascular Fraction Revenue in 2020
Figure 21. Global Stromal Vascular Fraction Revenue Market Share by Type (2016-2021)
Figure 22. Global Stromal Vascular Fraction Revenue Market Share by Type (2022-2027)
Figure 23. North America Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Stromal Vascular Fraction Market Share by Type (2016-2027)
Figure 25. North America Stromal Vascular Fraction Market Share by Application (2016-2027)
Figure 26. North America Stromal Vascular Fraction Market Share by Country (2016-2027)
Figure 27. United States Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Stromal Vascular Fraction Market Share by Type (2016-2027)
Figure 31. Europe Stromal Vascular Fraction Market Share by Application (2016-2027)
Figure 32. Europe Stromal Vascular Fraction Market Share by Country (2016-2027)
Figure 33. Germany Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Stromal Vascular Fraction Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Stromal Vascular Fraction Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Stromal Vascular Fraction Market Share by Region (2016-2027)
Figure 43. China Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Stromal Vascular Fraction Market Share by Type (2016-2027)
Figure 51. Latin America Stromal Vascular Fraction Market Share by Application (2016-2027)
Figure 52. Latin America Stromal Vascular Fraction Market Share by Country (2016-2027)
Figure 53. Mexico Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Stromal Vascular Fraction Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Stromal Vascular Fraction Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Stromal Vascular Fraction Market Share by Country (2016-2027)
Figure 59. Turkey Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Stromal Vascular Fraction Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Cytori Therapeutics Revenue Growth Rate in Stromal Vascular Fraction Business (2016-2021)
Figure 63. GE Healthcare Revenue Growth Rate in Stromal Vascular Fraction Business (2016-2021)
Figure 64. Ingeneron Revenue Growth Rate in Stromal Vascular Fraction Business (2016-2021)
Figure 65. Medikan International Revenue Growth Rate in Stromal Vascular Fraction Business (2016-2021)
Figure 66. Tissue Genesis Revenue Growth Rate in Stromal Vascular Fraction Business (2016-2021)
Figure 67. Genesis Biosystems Revenue Growth Rate in Stromal Vascular Fraction Business (2016-2021)
Figure 68. Human Med Revenue Growth Rate in Stromal Vascular Fraction Business (2016-2021)
Figure 69. IntelliCell BioSciences Revenue Growth Rate in Stromal Vascular Fraction Business (2016-2021)
Figure 70. LifeCell Revenue Growth Rate in Stromal Vascular Fraction Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed